A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women

Archives of General Psychiatry

Volumn 60, Issue 10, 2003, Pages 1017-1023

  Melke, Jonas ^a   Westberg, Lars ^a   Nilsson, Staffan ^a,b   Landén, Mikael ^a   Soderstrom, Henrik ^a,c   Baghaei, Fariba ^a   Rosmond, Roland ^a   Holm, Göran ^a   Björntorp, Per ^a   Nilsson, Lars Göran ^d   Adolfsson, Rolf ^e   Eriksson, Elias ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c Department of Forensic Chemistry and Genetics   (Sweden)

^d STOCKHOLM UNIVERSITY   (Sweden)

^e UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN 3 RECEPTOR;

5' UNTRANSLATED REGION; ADULT; AGGRESSION; ALLELE; ANTICIPATION; ARTICLE; ASTHENIA; AVOIDANCE BEHAVIOR; FATIGUE; FEAR; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IRRITABILITY; PERSONALITY; RECEPTOR GENE; SEROTONIN RECEPTOR 3A GENE; SEROTONIN RECEPTOR 3B GENE; SOCIAL DESIRABILITY; TEMPERAMENT; VERBAL BEHAVIOR;

ADULT; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PERSONALITY; PERSONALITY ASSESSMENT; PERSONALITY INVENTORY; POLYMORPHISM, GENETIC; RECEPTORS, SEROTONIN, 5-HT3; SERINE ENDOPEPTIDASES; SWEDEN;

EID: 10744223528     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.60.10.1017     Document Type: Article

References (67)

1. Gustavsson JP, Pedersen NL, Asberg M, Schalling D. Origins of individual differences in anxiety proneness: a twin/adoption study of the anxiety-related scales from the Karolinska Scales of Personality (KSP). Acta Psychiatr Scand. 1996;93:460-469.
2. Loehlin JC. Genes and Environment in Personality Development. Newbury Park, Calif: Sage Publications; 1992.
3. Cloninger CR, Van Eerdewegh P, Goate A, Edenberg HJ, Blangero J, Hesselbrock V, Reich T, Nurnberger J Jr, Schuckit M, Porjesz B, Crowe R, Rice JP, Foroud T, Przybeck TR, Almasy L, Bucholz K, Wu W, Shears S, Carr K, Crose C, Willig C, Zhao J, Tischfield JA, Li TK, Conneally PM, et al. Anxiety proneness linked to epistatic loci in genome scan of human personality traits. Am J Med Genet. 1998;81:313-317.
4. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat Genet. 1996;12:81-84.
5. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Nemanov L, Katz M, Belmaker RH. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet. 1996;12:78-80.
6. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527-1531.
7. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev. 1986;4:167-226.
8. Cloninger CR. A systematic method for clinical description and classification of personality variants: a proposal. Arch Gen Psychiatry. 1987;44:573-588.
9. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50:975-990.
10. Zuckerman M. Sensation seeking, mania, and monoamines. Neuropsychobiology. 1985;13:121-128.
11. Coccaro EF. Central serotonin and impulsive aggression. Br J Psychiatry Suppl. 1989;8:52-62.
12. Schalling D, Asberg M, Levander S. Impulsivity, nonconformity and sensation seeking as related to biological markers for vulnerability. Clin Neuropharmacol. 1984;7:756-757.
13. Lesch KP, Merschdorf U. Impulsivity, aggression, and serotonin: a molecular psychobiological perspective. Behav Sci Law. 2000;18:581-604.
14. Greenberg BD, Li Q, Lucas FR, Hu S, Sirota LA, Benjamin J, Lesch KP, Hamer DH, Murphy DL. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet. 2000;96:202-216.
15. Melke J, Landen M, Baghei F, Rosmond R, Holm G, Bjorntorp P. Westberg L, Hellstrand M, Eriksson E. Serotonin transporter gene polymorphisms are associated with anxiety-related personality traits in women. Am J Med Genet. 2001;105:458-463.
16. Ebstein RP, Segman R, Benjamin J, Osher Y, Nemanov L, Belmaker RH. 5-HT2C (HTR2C) serotonin receptor gene polymorphism associated with the human personality trait of reward dependence: interaction with dopamine D4 receptor (D4DR) and dopamine D3 receptor (D3DR) polymorphisms. Am J Med Genet. 1997;74:65-72.
17. Kuhn KU, Meyer K, Nothen MM, Gansicke M, Papassotiropoulos A, Maier W. Allelic variants of dopamine receptor D4 (DRD4) and serotonin receptor 5HT2c (HTR2c) and temperament factors: replication tests. Am J Med Genet. 1999;88:168-172.
18. Nielsen DA, Virkkunen M, Lappalainen J, Eggert M, Brown GL, Long JC, Goldman D, Linnoila M. A tryptophan hydroxylase gene marker for suicidality and alcoholism. Arch Gen Psychiatry. 1998;55:593-602.
19. Ye JH, Ponnudurai R, Schaefer R. Ondansetron: a selective 5-HT(3) receptorantagonist and its applications in CNS-related disorders. CNS Drug Rev. 2001;7:199-213.
20. Matsumoto M, Yoshioka M, Togashi H, Tochihara M, Ikeda T, Saito H. Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis. J Pharmacol Exp Ther. 1995;272:1044-1051.
21. Giovannini MG, Ceccarelli I, Molinari B, Cecchi M, Goldfarb J, Blandina P. Serotonergic modulation of acetylcholine release from cortex of freely moving rats. J Pharmacol Exp Ther. 1998;285:1219-1225.
22. Bloom FE, Morales M. The central 5-HT3 receptor in CNS disorders. Neurochem Res. 1998;23:653-659.
23. Tricklebank MD. The functional importance of 5-HT3 receptors in the interactions between serotoninergic and dopaminergic systems in the CNS. In: Hamen M, ed. Central and Peripheral 5-HT3 Receptors. London, England: Academic Press; 1992:189-205.
24. Benloucif S, Keegan MJ, 6alloway MP. Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J Pharmacol Exp Ther. 1993;265:373-377.
25. Faris PL, Kim SW, Meller WH, Goodale RL, Oakman SA, Hofbauer RD, Marshall AM, Daughters RS, Banerjee-Stevens D, Eckert ED, Hartman BK. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial. Lancet. 2000;355:792-797.
26. Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial. JAMA. 2000;284:963-971.
27. McBride WJ, Li TK. Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol. 1998;12:339-369.
28. Sirota P, Mosheva T, Shabtay H, Giladi N, Korczyn AD. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia. Am J Psychiatry. 2000;157:287-289.
29. Olivier B, van Wijngaarden I, Soudijn W. 5-HT(3) receptor antagonists and anxiety: a preclinical and clinical review. Eur Neuropsychopharmacol. 2000;10:77-95.
30. Miyake A, Mochizuki S, Takemoto Y, Akuzawa S. Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species. Mol Pharmacol. 1995;48:407-416.
31. Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF. The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature. 1999;397:359-363.
32. Niesler B, Flohr T, Nothen MM, Fischer C, Rietschel M, Franzek E, Albus M, Propping P, Rappold GA. Association between the 5′ UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics. 2001;11:471-475.
33. Niesler B, Weiss B, Fischer C, Nothen MM, Propping P, Bondy B, Rietschel M, Maier W, Albus M, Franzek E, Rappold GA. Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients. Pharmacogenetics. 2001;11:21-27.
34. Gutierrez B, Arranz MJ, Huezo-Diaz P, Dempster D, Matthiasson P, Travis M, Munro J, Osborne S, Kerwin RW. Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response. Schizophr Res. 2002;58:93-97.
35. Rosmond R, Bjorntorp P. Psychiatric ill-health of women and its relationship to obesity and body fat distribution. Obes Res. 1998;6:338-345.
36. Nilsson L-G, Bäckman L, Erngrund K, Nyberg L, Adolfsson R, Bucht G, Karlsson S, Widing M, Winblad B. The Betula Prospective Cohort Study: memory, health, and aging. Aging Neuropsychol Cogn. 1997;4:1-32.
37. Brandstrom S, Schlette P, Przybeck TR, Lundberg M, Forsgren T, Sigvardsson S, Nylander PO, Nilsson LG, Cloninger RC, Adolfsson R. Swedish normative data on personality using the Temperament and Character Inventory. Compr Psychiatry. 1998;39:122-128.
38. Schalling D, Asberg M, Edman G, Oreland L. Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity. Acta Psychiatry Scand. 1987;76:172-182.
39. Farde L, Gustavsson JP, Jonsson E. D2 dopamine receptors and personality traits [letter]. Nature. 1997;385:590.
40. Virkkunen M, Kallio E, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C, Bissette G, Kalogeras K, Karonen SL, et al. Personality profiles and state aggressiveness in Finnish alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry. 1994;51:28-33.
41. Gustavsson JP, Weinryb RM, Goransson S, Pedersen NL, Asberg M. Stability and predictive ability of personality traits across 9 years. Pers Indiv Diff. 1997;22:783-791.
42. Westberg L, Melke J, Landén M, Nilsson S, Baghaei F, Rosmond R, Jansson M, Holm G, Björntorp P, Eriksson E. Association between a dinucleotide repeat polymorphism of the estrogen receptor alpha gene and personality traits in women. Mol Psychiatry. 2003;8:118-122.
43. Nordfors L, Jansson M, Sandberg G, Lavebratt C, Sengul S, Schalling M, Arner P. Large-scale genotyping of single nucleotide polymorphisms by Pyrosequencing™ and validation against the 5′ nuclease (Taqman®) assay. Hum Mutat. 2002; 19:395-401.
44. Nilsson S. Which Genes are Involved? Statistical Planning and Analysis of Human Genetic Samples [thesis]. Göteborg, Sweden: Department of Mathematical Statistics, Chalmers Unversity of Technology; 2001.
45. Westfall P, Young S. Resampling-Based Multiple Testing: Examples and Methods for P-Value Adjustment. New York, NY: John Wiley & Sons Inc; 1993.
46. Cloninger CR, Bayon C, Svrakic DM. Measurement of temperament and character in mood disorders: a model of fundamental states as personality types. J Affect Disord. 1998;51:21-32.
47. Curtin F, Walker JP, Baden M, Schulz P. The relations between scores on analogous scales from four personality questionnaires in 50 normal men. Pers Indiv Diff. 1995;19:705-711.
48. Ruegg RG, Gilmore J, Ekstrom RD, Corrigan M, Knight B, Tancer M, Leatherman ME, Carson SW, Golden RN. Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects. Biol Psychiatry. 1997;42:1123-1129.
49. Gerra G, Zaimovic A, Timpano M, Zambelli U, Delsignore R, Brambilla F. Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology. 2000;25:479-496.
50. Hennig J, Toll C, Schonlau P, Rohrmann S, Netter P. Endocrine responses after d-fenfluramine and ipsapirone challenge: further support for Cloninger's tridimensional model of personality. Neuropsychobiology. 2000;41:38-47.
51. Hansenne M, Ansseau M. Harm avoidance and serotonin. Biol Psychol. 1999;51:77-81.
52. Allgulander C, Cloninger CR, Przybeck TR, Brandt L. Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with generalized anxiety disorder. Psychopharmacol Bull. 1998;34:165-166.
53. Joffe RT, Bagby RM, Levitt AJ, Regan JJ, Parker JD. The Tridimensional Personality Questionnaire in major depression. Am J Psychiatry. 1993;150:959-960.
54. Brody AL, Saxena S, Fairbanks LA, Alborzian S, Demaree HA, Maidment KM, Baxter LR Jr. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine. J Clin Psychiatry. 2000;61:349-355.
55. Mazzanti CM, Lappalainen J, Long JC, Bengel D, Naukkarinen H, Eggert M, Virkkunen M, Linnoila M, Goldman D. Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry. 1998;55:936-940.
56. Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH. No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol Psychiatry. 1997;2:224-226.
57. Blairy S, Massat I, Staner L, Le Bon O, Van Gestel S, Van Broeckhoven C, Hilger C, Hentges F, Souery D, Mendlewicz J. 5-HT2a receptor polymorphism gene in bipolar disorder and harm avoidance personality trait. Am J Med Genet. 2000;96:360-364.
58. Kusumi I, Suzuki K, Sasaki Y, Kameda K, Sasaki T, Koyama T. Serotonin 5-HT (2A) receptor gene polymorphism, 5-HT(2A) receptor function and personality traits in healthy subjects: a negative study. J Affect Disord. 2002:68:235-241.
59. Eriksson E, Humble M. Serotonin in psychiatric pathophysiology: a review of data from experimental and clinical research. Prog Basic Clin Pharmacol. 1990;3:66-119.
60. Manuck SB, Flory JD, McCaffery JM, Matthews KA, Mann JJ, Muldoon MF. Aggression, impulsivity, and central nervous system serotonergic responsivity in a nonpatient sample. Neuropsychopharmacology. 1998;19:287-299.
61. Cleare AJ, Bond AJ. The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects. Psychopharmacology. 1995;118:72-81.
62. Moeller FG, Dougherty DM, Swann AC, Collins D, Davis CM, Cherek DR. Tryptophan depletion and aggressive responding in healthy males. Psychopharmacology. 1996;126:97-103.
63. Fuller RW. The influence of fluoxetine on aggressive behavior. Neuropsychopharmacology. 1996;14:77-81.
64. Eriksson E. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria. Int Clin Psychopharmacol. 1999;14(suppl 2):S27-S33.
65. Rudissaar R, Pruus K, Skrebuhhova T, Allikmets L, Matto V. Modulatory role of 5-HT3 receptors in mediation of apomorphine-induced aggressive behaviour in male rats. Behav Brain Res. 1999;106:91-96.
66. Poncelet M, Perio A, Simiand J, Gout G, Soubrie P, Le Fur G. Antidepressant-like effects of SR 57227A, a 5-HT3 receptor agonist, in rodents. J Neural Transm Gen Sect. 1995;102:83-90.
67. Chotai J, Forsgren T, Nilsson LG, Adolfsson R. Season of birth variations in the temperament and character inventory of personality in a general population. Neuropsychobiology. 2001;44:19-26.